V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210122 | 20078231 | 1.77 | null | Palliative (P) | 2018-08-02 | 2018-08-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100772467 |
| 20210125 | 20078232 | 1.78 | 87.25 | null | 2016-05-02 | 2017-05-18 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100927612 |
| 20210126 | 20078233 | 1.82 | 78 | null | 2017-12-30 | 2017-12-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100806725 |
| 20210127 | 20078234 | 1.66 | 83.5 | Palliative (P) | 2019-12-28 | 2020-01-03 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100807196 |
| 20210133 | 20078235 | 1.57 | 91.4 | Palliative (P) | 2017-02-03 | 2017-02-25 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101202888 |
| 20210139 | 20078236 | 1.69 | 84.6 | Neo-adjuvant (N) | null | 2018-01-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101490515 |
| 20210149 | 20078237 | 1.78 | 91 | Palliative (P) | 2019-02-15 | 2019-03-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101282850 |
| 20210151 | 20078238 | 1.65 | 71.8 | Palliative (P) | 2018-04-09 | 2018-04-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101712713 |
| 20210161 | 20078240 | 1.73 | 107.3 | Curative (C) | null | 2016-08-31 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101442569 |
| 20210167 | 20078241 | 1.69 | 65.5 | Neo-adjuvant (N) | 2020-08-03 | 2020-08-10 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100526997 |
| 20210169 | 20078242 | 1.73 | 109.8 | Palliative (P) | 2019-08-03 | 2019-08-03 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101101968 |
| 20210180 | 20078243 | 1.84 | 67 | Palliative (P) | 2017-01-20 | 2017-02-01 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100354066 |
| 20210183 | 20078244 | 1.69 | 71.55 | Palliative (P) | 2017-01-05 | 2017-01-22 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100267213 |
| 20210190 | 20078245 | 0 | 0 | Palliative (P) | 2018-02-08 | 2018-03-07 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100919470 |
| 20210196 | 20078246 | 0 | 89.5 | Curative (C) | 2019-04-18 | 2019-04-25 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100768231 |
| 20210199 | 20078247 | 1.54 | 105 | null | 2016-07-13 | 2016-07-19 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101660698 |
| 20210201 | 20078248 | 1.7 | 75.6 | Palliative (P) | 2018-07-29 | 2018-07-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100201196 |
| 20210202 | 20078249 | 1.79 | 89.9 | Adjuvant (A) | 2018-11-29 | 2018-12-25 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100601781 |
| 20210204 | 20078250 | 0 | 0 | Palliative (P) | null | 2018-03-04 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100822325 |
| 20210211 | 20078251 | 1.52 | 79.2 | null | 2017-06-19 | 2017-09-27 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 101313614 |
| 20210215 | 20078252 | 1.65 | 78.9 | Curative (C) | 2019-09-06 | 2019-09-13 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100425927 |
| 20210216 | 20078253 | 1.65 | 51.35 | Neo-adjuvant (N) | 2020-02-06 | 2020-02-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100163435 |
| 20210227 | 20078254 | 1.53 | 74 | Palliative (P) | 2018-02-17 | 2018-03-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101314747 |
| 20210235 | 20078255 | 1.75 | 63.2 | null | 2018-07-21 | 2018-07-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100368579 |
| 20210238 | 20078256 | 1.58 | 113.6 | 03 | 2019-04-03 | 2019-04-07 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100660603 |
| 20210239 | 20078257 | 1.7 | 76.6 | Palliative (P) | 2019-01-27 | 2019-02-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100529696 |
| 20210241 | 20078258 | 1.62 | 100 | Neo-adjuvant (N) | 2016-09-30 | 2016-10-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100538103 |
| 20210244 | 20078259 | 1.63 | 82 | Palliative (P) | 2017-04-14 | 2017-04-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101203875 |
| 20210246 | 20078260 | 1.85 | 55.8 | Curative (C) | 2017-05-21 | 2017-05-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100555269 |
| 20210255 | 20078261 | 1.79 | 69 | Palliative (P) | 2019-08-28 | 2019-08-30 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101830375 |
| 20210261 | 20078262 | 1.61 | 84.4 | 03 | 2018-03-25 | 2018-04-01 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101163381 |
| 20210268 | 20078263 | 1.61 | 70.8 | Neo-adjuvant (N) | 2019-08-31 | 2019-09-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100547071 |
| 20210272 | 20078264 | 1.75 | 50.75 | Curative (C) | 2017-07-05 | 2017-07-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100620408 |
| 20210273 | 20078265 | null | 80.3 | null | 2019-07-11 | 2019-07-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100925425 |
| 20210274 | 20078266 | 1.7 | 78.9 | Neo-adjuvant (N) | 2017-02-20 | 2017-03-07 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100990266 |
| 20210275 | 20078267 | 0 | 0 | Palliative (P) | 2017-06-15 | 2017-07-16 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101198850 |
| 20210285 | 20078268 | 1.82 | 95.4 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-15 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100822570 |
| 20210292 | 20078269 | 1.79 | 61.5 | Palliative (P) | 2016-08-20 | 2016-08-20 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101050648 |
| 20210293 | 20078270 | null | 63 | Palliative (P) | 2018-06-13 | 2018-06-29 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101666937 |
| 20210295 | 20078271 | 1.73 | 46.8 | Palliative (P) | null | 2018-03-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101203155 |
| 20210300 | 20078272 | 1.69 | 64 | Palliative (P) | 2018-09-12 | 2018-09-13 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100482082 |
| 20210303 | 20078273 | 1.71 | 78.9 | Palliative (P) | 2017-10-30 | 2017-11-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101119865 |
| 20210304 | 20078274 | 1.63 | 54 | Neo-adjuvant (N) | 2018-07-16 | 2018-07-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100653046 |
| 20210309 | 20078275 | 0 | 0 | Palliative (P) | 2018-10-19 | 2018-11-15 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100481890 |
| 20210310 | 20078276 | 1.64 | 46 | Palliative (P) | 2018-05-14 | 2018-05-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100216277 |
| 20210312 | 20078277 | 1.65 | null | Palliative (P) | null | 2019-07-16 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101037553 |
| 20210314 | 20078278 | 1.53 | 0 | Palliative (P) | 2017-03-19 | 2017-04-01 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100827564 |
| 20210315 | 20078279 | 1.7 | 56 | Adjuvant (A) | 2017-04-02 | 2017-04-14 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100988918 |
| 20210318 | 20078280 | 1.85 | 77.9 | 03 | 2017-01-16 | 2017-01-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100713414 |
| 20210319 | 20078281 | 1.6 | 78.5 | Adjuvant (A) | 2019-05-17 | 2019-05-27 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100923327 |